TLDR
- Rocket Lab stock fell 9% in pre-market trading after Q2 2026 earnings
- Revenue hit a record $234 million, up 62% year-over-year, beating estimates
- Q3 GAAP gross margin guidance of 29%–31% came in well below the Street’s ~37.6% estimate
- The stock had already gained ~27% in the week before earnings, leaving it exposed to a pullback
- Record backlog of $2.36 billion and a $397 million Space Force contract are bright spots
Rocket Lab stock dropped 9% in pre-market trading on Tuesday after its Q2 2026 earnings report left the market cold on profitability.
The company posted record revenue of $234 million for the quarter, up 62% year-over-year and just ahead of the $232 million analyst consensus. But that wasn’t enough to hold the stock up.
The adjusted loss per share came in at $0.08, missing expectations. More damaging was the Q3 GAAP gross margin guidance of 29%–31%, well short of the Street’s estimate of around 37.6%.
ROCKET LAB $RKLB Q2’26 EARNINGS HIGHLIGHTS
🔹 Revenue: $234M (Est. $231M) 🟢; +62% YoY
🔹 EPS: -$0.08 (Est. -$0.07) 🔴
🔹 Backlog: $2.36B; +137% YoYQ3 Guide:
🔹 Revenue: $250M-$265M (Est. $239M) 🟢
🔹 EBITDA: $17M-$23M loss (Est. -$11.8M) 🔴
🔹 GAAP Gross Margin: 29%-31%
🔹… pic.twitter.com/oQjfJgCYRf— Wall St Engine (@wallstengine) August 10, 2026
The stock had already run roughly 27% in the week leading up to the print. That setup made it vulnerable when the numbers disappointed on profitability.
The margin pressure is being tied to a shift in business mix. Lower-margin satellite platform sales made up a larger share of Space Systems revenue in the quarter.
Non-GAAP gross margin came in at 41.5% for Q2, topping the 38% analysts had expected. But the forward guide overshadowed that beat.
Q3 Outlook and the Iridium Overhang
Management guided Q3 revenue between $250 million and $265 million, well above the $235.9 million consensus. But the gross margin step-down was the headline that moved the stock.
Non-GAAP gross margin for Q3 is expected between 35% and 37%, down from 41.5%. Adjusted EBITDA loss is projected between $17 million and $23 million.
The pending $8 billion Iridium acquisition is adding another layer of uncertainty. Around 41 million preferred shares are embedded in Q3 guidance, raising dilution concerns among investors.
The selloff extended from after-hours Monday into Tuesday’s pre-market. The broader market gave no cover, with the S&P 500 and Nasdaq both essentially flat on the day.
Contracts and Backlog Stay Strong
Rocket Lab finished the quarter with a record backlog of $2.36 billion. That includes more than 90 missions in its launch pipeline.
Last week, the company announced a $397 million U.S. Space Force contract covering development and launch of Flatellite spacecraft aboard the Neutron rocket.
Neutron’s Stage 1 tank production remains on track for delivery to the launch pad in Q4. That milestone is a key part of the company’s longer-term growth story.
Rocket Lab also completed its Mynaric and Motiv acquisitions earlier this year, adding technologies to its spacecraft and space systems portfolio.
The stock carries a Strong Buy consensus rating from analysts, with 13 Buys and 4 Holds over the past three months. The average price target is $110.53, implying around 38% upside from Monday’s close.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
